Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Learn how to effectively use credit card points for international flights. Turn your rewards into unforgettable trips.
19,198 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
A five week surge in spot Bitcoin ETF inflows signals renewed institutional interest as hedging flows fade. This arti...
Solana just overtook Ethereum in developer signups, marking a major shift in blockchain mindshare. The latest data po...
The POWI 2026 earnings transcript sheds light on how the company performed in Q1 and what the path ahead could look l...
Major DeFi protocols are migrating to Chainlink's CCIP after a $292 million KelpDAO exploit, pushing LINK higher as t...
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
The AI wave has reignited cloud growth, and Q1 brought sharper momentum across the big three. This analysis highlight...
RAD Intel debuts a Regulation A+ offering at $0.91 per share, pitching an AI-driven marketing engine as the next oppo...
Cerebras just pulled biggest IPO momentum sent shockwaves through tech stocks. This article breaks down what that imp...
Warren Buffett's century-spanning Dow forecast remains a talking point as the index sits in the mid-30,000s in 2026. ...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...